HeartBeam, Inc. (BEAT)
NASDAQ: BEAT · Real-Time Price · USD
1.350
+0.080 (6.30%)
At close: Aug 29, 2025, 4:00 PM
1.400
+0.050 (3.70%)
After-hours: Aug 29, 2025, 7:58 PM EDT
HeartBeam Market Cap
HeartBeam has a market cap or net worth of $46.32 million as of August 29, 2025. Its market cap has decreased by -23.18% in one year.
Market Cap
46.32M
Enterprise Value
41.27M
1-Year Change
-23.18%
Ranking
Category
Stock Price
$1.35
Market Cap Chart
Since the IPO on November 11, 2021, HeartBeam's market cap has decreased from $46.53M to $46.32M, a decrease of -0.45%. That is a compound annual growth rate of -0.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 46.32M | -25.33% |
| Dec 31, 2024 | 62.04M | 0.26% |
| Dec 29, 2023 | 61.87M | 58.40% |
| Dec 30, 2022 | 39.06M | 62.39% |
| Dec 31, 2021 | 24.05M | -48.30% |
| Nov 11, 2021 | 46.53M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 657.66B |
| Johnson & Johnson | 426.69B |
| AbbVie | 371.68B |
| UnitedHealth Group | 280.64B |
| Novo Nordisk | 249.87B |
| AstraZeneca | 246.96B |
| Novartis AG | 244.78B |
| Abbott Laboratories | 230.89B |